Skip to main content

AusPAR: Comirnaty Original / Omicron BA.1 COVID-19 Vaccine

Australian Public Assessment Report
Device/Product Name
Comirnaty Original/Omicron BA.1 COVID-19 Vaccine
Active ingredients
Tozinameran and riltozinameran
AusPAR Date
Submission Number
Submission Type
New biological entity/new combination of a previously approved and a new active ingredient
Approved for provisional registration

Help us improve the Therapeutic Goods Administration site